4.5 Article

Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant

Journal

JOURNAL OF HEART AND LUNG TRANSPLANTATION
Volume 40, Issue 9, Pages 970-980

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.healun.2021.06.002

Keywords

heart transplantation; primary graft dysfunction; ischemia-reperfusion injury; clinical risk prediction

Ask authors/readers for more resources

The study identified recipient, donor, and surgical risk factors associated with severe primary graft dysfunction (PGD) following heart transplant, and developed a clinical risk score (ABCE) that showed good discrimination and calibration for severe PGD. Further research into the underlying mechanisms of PGD development is urgently needed to better understand the differing pathophysiology of mild/moderate and severe PGD.
BACKGROUND: Primary graft dysfunction (PGD) is a major cause of early mortality following heart transplant (HT). The International Society for Heart and Lung Transplantation (ISHLT) subdivides PGD into 3 grades of increasing severity. Most studies have assessed risk factors for PGD without distinguishing between PGD severity grade. We sought to identify recipient, donor and surgical risk factors specifically associated with mild/moderate or severe PGD. METHODS: We identified 734 heart transplant recipients at our institution transplanted between January 1, 2012 and December 31, 2018. PGD was defined according to modified ISHLT criteria. Recipient, donor and surgical variables were analyzed by multinomial logistic regression with mild/moderate or severe PGD as the response. Variables significant in single variable modeling were subject to multivariable analysis via penalized logistic regression. RESULTS: PGD occurred in 24% of the cohort (n = 178) of whom 6% (n = 44) had severe PGD. One-year sur-vival was reduced in recipients with severe PGD but not in those with mild or moderate PGD. Multivariable analysis identified 3 recipient factors: prior cardiac surgery, recipient treatment with ACEI/ARB/ARNI plus MRA, recipient treatment with amiodarone plus beta-blocker, and 3 surgical factors: longer ischemic time, more red blood cell transfusions, and more platelet transfusions, that were associated with severe PGD. We developed a clinical risk score, ABCE, which provided acceptable discrimination and calibration for severe PGD. CONCLUSIONS: Risk factors for mild/moderate PGD were largely distinct from those for severe PGD, suggesting a differing pathophysiology involving several biological pathways. Further research into mechanisms underlying the development of PGD is urgently needed. J Heart Lung Transplant 2021;40:970-980 (c) 2021 International Society for Heart and Lung Transplantation. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available